Hillhouse-Backed Genor Plans $200 Million Hong Kong IPO

(Bloomberg) -- Genor Biopharma Co. is planning an initial public offering in Hong Kong that could raise about $200 million, according to people familiar with the matter.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.